首页> 美国卫生研究院文献>BMJ Case Reports >Two for the price of one: emerging carbapenemases in a returning traveller to New York City
【2h】

Two for the price of one: emerging carbapenemases in a returning traveller to New York City

机译:两个价格为一:在纽约的返回旅行者中出现的碳结甲酶

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report a case of a complex orthopaedic infection in a patient returning to New York City from Bangladesh where he was involved in a serious motor vehicle accident. He developed extensive osteomyelitis with a carbapenem-resistant Klebsiella pneumoniae. The isolate was unique due to the coexistence of New Delhi metallo-β-lactamase-1 and Oxacillinase type-181 carbapenemases, which are relatively uncommon in North America and were presumably acquired in Bangladesh. Herein, we explore challenges associated with management of carbapenem-resistant Enterobacteriaceae infections, including limited available data on effective antimicrobial therapy. We also highlight the added value of rapid diagnostic technology in guiding clinical management. Ultimately, the patient required both aggressive surgical management and combination therapy with aztreonam and ceftazidime-avibactam for true source control and favourable clinical outcome.
机译:我们举报了在从孟加拉国回到纽约市的患者中复杂骨科感染的情况,他参与了严重的机动车事故。他用耐肉豆蔻肺癌肺炎造成了广泛的骨髓炎。由于新德里金属-β-乳酰胺酶-1和恶毒酶酶-181碳结构酶的共存,分离物是独一无二的,这在北美相对罕见,并且在孟加拉国被收购。在此,我们探讨与耐药肠杆菌菌感染的管理相关的挑战,包括有关有效抗微生物治疗的可用数据。我们还突出了快速诊断技术在引导临床管理中的附加值。最终,患者需要与AztReonam和Ceftazidime-Avibactam进行侵略性手术管理和联合治疗,用于真正的源源控制和有利的临床结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号